Considering a reverse merger as a path to public markets? Our Brookline attorneys specialize in reverse mergers, shell company transactions, and Form 211 filings for companies across Healthcare, Education, Technology.
Our managing partner provides selective reverse merger law counsel to clients in Brookline and nationwide, including:
We engage selectively with capitalized founders and investors in Brookline and nationwide:
Boston is the global epicenter of biotech and life sciences M&A, with Kendall Square and the Route 128 corridor housing the densest concentration of biotech companies outside San Francisco. Beyond life sciences, the region drives significant deal activity in financial technology, education technology, and defense contracting. The region's deep research university ecosystem (MIT, Harvard, Tufts) produces a steady stream of spinoff companies ripe for acquisition.
Boston's biotech-heavy deal market means acquirers often face complex IP due diligence involving university licenses, clinical trial data, and FDA regulatory considerations. Competition from large pharma strategic acquirers can push valuations higher for promising targets.
Boston's concentration of world-class research institutions and highly educated workforce creates a self-reinforcing ecosystem where acquired companies can access talent, partnerships, and capital unavailable in other markets.
Massachusetts enacted the Noncompetition Agreement Act in 2018, limiting non-competes to 12 months and requiring garden leave pay - buyers must evaluate existing employee agreements during due diligence as many pre-2018 agreements may now be unenforceable.
"A reverse merger can be the fastest path to public markets, but it can also be the fastest path to an SEC enforcement action if the shell company has undisclosed liabilities. The due diligence on the shell is more important than the due diligence on the operating company."
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
Entity mergers and conversions require filing with the Massachusetts Secretary of the Commonwealth, Corporations Division. The Department of Revenue requires tax waivers for asset purchases. Professional corporations require additional filings with the relevant licensing board.
Submit your transaction details for a preliminary assessment by our managing partner.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Common questions from Brookline clients
Submit your transaction details for a preliminary assessment by our managing partner
Submit Transaction DetailsIn-depth guides to help you prepare for your transaction
State-by-state securities registration requirements and exemptions.
Read guideHow private companies can issue equity compensation under Rule 701.
Read guideFiling requirements for Regulation D offerings at the state level.
Read guideHow reverse mergers work and when they make sense as a path to going public.
Read guideRequirements for selling restricted and control securities.
Read guideOur managing partner provides selective reverse merger law counsel for transactions nationwide. Submit your transaction details for a preliminary assessment.
Submit transaction details for review. We engage selectively with capitalized buyers and sellers.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Selective M&A practice - Nationwide reach - Managing partner on every deal